Insights

Strong Industry Recognition Viva Biotech's recent awards for technological innovation and influence in preclinical research highlight its leadership position and credibility in the biotech industry, making it an attractive partner for companies seeking cutting-edge drug discovery collaborations.

Innovative Technology Platforms The launch of advanced platforms such as AI-Driven Drug Discovery and V-DEL showcases Viva Biotech's commitment to leveraging next-generation technology, providing opportunities to offer tailored solutions or integrations to enhance their research capabilities and expand service offerings.

Robust Funding and Growth With recent investments totaling approximately $210 million and additional funding secured, Viva Biotech is poised for expansion and increased R&D efforts, indicating a high potential for upselling integrated or value-added services to further accelerate their innovation pipeline.

Global Market Position Operating in a competitive landscape with prominent companies like Charles River and Pharmaron, Viva Biotech's strategic focus on early-stage to late-phase drug development creates opportunities for partnerships with biotech startups and pharma companies looking for comprehensive R&D solutions.

Expanding Service Portfolio Viva Biotech's broad spectrum of services from structural biology to manufacturing, combined with their focus on synthetic chemistry and bioassays, presents multiple avenues for cross-selling complementary services or co-developing bespoke research solutions for biotech clients aiming to streamline drug discovery processes.

Viva Biotech Tech Stack

Viva Biotech uses 8 technology products and services including Open Graph, Swiper, jQuery, and more. Explore Viva Biotech's tech stack below.

  • Open Graph
    Content Management System
  • Swiper
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Wow
    Marketing Analytics
  • HubSpot
    Marketing Automation
  • Google Analytics
    Web Analytics
  • Tengine
    Web And Application Servers
  • jQuery Waypoints
    Web Tools And Plugins

Media & News

Viva Biotech's Email Address Formats

Viva Biotech uses at least 1 format(s):
Viva Biotech Email FormatsExamplePercentage
First.Last@vivabiotech.comJohn.Doe@vivabiotech.com
70%
Last.First@vivabiotech.comDoe.John@vivabiotech.com
13%
FirLast@vivabiotech.comJohDoe@vivabiotech.com
8%
FirstLast@vivabiotech.comJohnDoe@vivabiotech.com
9%

Frequently Asked Questions

What is Viva Biotech's official website and social media links?

Minus sign iconPlus sign icon
Viva Biotech's official website is vivabiotech.com and has social profiles on LinkedInCrunchbase.

What is Viva Biotech's SIC code NAICS code?

Minus sign iconPlus sign icon
Viva Biotech's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Viva Biotech have currently?

Minus sign iconPlus sign icon
As of December 2025, Viva Biotech has approximately 1K employees across 4 continents, including AsiaNorth AmericaEurope. Key team members include Cso: Z. Y.Chief Innovation Officer, Head Of Investment: H. D.Vp & Head Of Early Discovery Platforms: B. X.. Explore Viva Biotech's employee directory with LeadIQ.

What industry does Viva Biotech belong to?

Minus sign iconPlus sign icon
Viva Biotech operates in the Biotechnology Research industry.

What technology does Viva Biotech use?

Minus sign iconPlus sign icon
Viva Biotech's tech stack includes Open GraphSwiperjQueryWowHubSpotGoogle AnalyticsTenginejQuery Waypoints.

What is Viva Biotech's email format?

Minus sign iconPlus sign icon
Viva Biotech's email format typically follows the pattern of First.Last@vivabiotech.com. Find more Viva Biotech email formats with LeadIQ.

How much funding has Viva Biotech raised to date?

Minus sign iconPlus sign icon
As of December 2025, Viva Biotech has raised $210M in funding. The last funding round occurred on Jun 13, 2023 for $210M.

When was Viva Biotech founded?

Minus sign iconPlus sign icon
Viva Biotech was founded in 2008.

Viva Biotech

Biotechnology ResearchShanghai, China1001-5000 Employees

Established in 2008, Viva Biotech (01873.HK) provides one-stop services ranging from early-stage Structure-Based Drug R&D to commercial manufacturing to global biopharmaceutical innovators. We offer leading early-stage to late-phase drug discovery expertise by integrating our dedicated team of experts, cutting-edge technology platforms, and state-of-the-art equipment in X-ray crystallization, Cryo-EM, DEL, ASMS, SPR, HDX, AIDD and CADD, and much more. Our business covers all aspects of therapeutic strategies and drug modalities, including small molecules and biologics across the pharma and biotech spectrum. The experienced chemistry team, led by senior medicinal chemists and drug discovery biologists, provides services for drug design, medicinal chemistry (hit to lead and lead optimization), custom synthesis, chemical analysis and purification, kilogram scale-up, peptide synthesis and corresponding bioassays. With our subsidiary, Langhua Pharma, we offer our worldwide pharmaceutical and biotech partners a one-stop integrated CMC (Chemical, Manufacturing, and Control) service from preclinical to commercial manufacturing. Additionally, Viva embedded an equity for service (EFS) model to high potential startups to address unmet medical needs.

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
1001-5000

Section iconFunding & Financials

  • $210M

    Viva Biotech has raised a total of $210M of funding over 3 rounds. Their latest funding round was raised on Jun 13, 2023 in the amount of $210M.

  • $50M$100M

    Viva Biotech's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $210M

    Viva Biotech has raised a total of $210M of funding over 3 rounds. Their latest funding round was raised on Jun 13, 2023 in the amount of $210M.

  • $50M$100M

    Viva Biotech's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.